| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Microbiology and Immunology, Morehouse School of Medicine, Atlanta, GA 30310;
Department of Biology, Spelman College, Atlanta, GA 30314; and
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333
A new paradigm for designing vaccines against certain microbial pathogens, including Chlamydia trachomatis, is based on the induction of local mucosal Th1 response. IL-10 is an anti-inflammatory cytokine that exerts negative immunoregulatory influence on Th1 response. This study investigated whether biochemical modulation of endogenous IL-10 expression at the level of APCs is a practical strategy for enhancing the specific Th1 response against pathogens controlled by Th1 immunity. The results revealed that the high resistance of genetically engineered IL-10-/- (IL-10KO) mice to genital chlamydial infection is a function of the predilection of their APCs to rapidly and preferentially activate a high Th1 response. Thus, in microbiological analysis, IL-10KO mice suffered a shorter duration of infection, less microbial burden, and limited ascending infection than immunocompetent wild-type mice. Also, IL-10KO were resistant to reinfection after 8 wk of the primary infection. Cellular and molecular immunologic evaluation indicated that IL-10KO mice induced greater frequency of chlamydial-specific Th1 response following C. trachomatis infection. Moreover, IL-10KO APCs or antisense IL-10 oligonucleotide-treated wild-type APCs were potent activators of Th1 response from naive or immune T cells. Furthermore, both Ag-pulsed dendritic cells from IL-10KO mice and IL-10 antisense-treated dendritic cells from wild-type mice were efficient cellular vaccines in adoptive immunotherapeutic vaccination against genital chlamydial infection. These findings may furnish a novel immunotherapeutic strategy for boosting the Th1 response against T cell-controlled pathogens and tumors, using IL-10-deficient APCs as vaccine delivery agents.
This article has been cited by other articles:
|
|
 |
|
  K. Breckpot, C. Aerts-Toegaert, C. Heirman, U. Peeters, R. Beyaert, J. L. Aerts, and K. Thielemans Attenuated Expression of A20 Markedly Increases the Efficacy of Double-Stranded RNA-Activated Dendritic Cells As an Anti-Cancer Vaccine J. Immunol., January 15, 2009; 182(2): 860 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Kaiko, S. Phipps, D. K. Hickey, C. E. Lam, P. M. Hansbro, P. S. Foster, and K. W. Beagley Chlamydia muridarum Infection Subverts Dendritic Cell Function to Promote Th2 Immunity and Airways Hyperreactivity J. Immunol., February 15, 2008; 180(4): 2225 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Natividad, M. J. Holland, K. A. Rockett, J. Forton, N. Faal, H. M. Joof, D. C.W. Mabey, R. L. Bailey, and D. P. Kwiatkowski Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation Hum. Mol. Genet., January 15, 2008; 17(2): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kornbluth and G. W. Stone Immunostimulatory combinations: designing the next generation of vaccine adjuvants J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawasaki, W. J. Hubbard, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Trauma-Hemorrhage Induces Depressed Splenic Dendritic Cell Functions in Mice J. Immunol., October 1, 2006; 177(7): 4514 - 4520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Chen, S. Louie, B. A. McCormick, W. A. Walker, and H. N. Shi Helminth-Primed Dendritic Cells Alter the Host Response to Enteric Bacterial Infection J. Immunol., January 1, 2006; 176(1): 472 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kamada, T. Hisamatsu, S. Okamoto, T. Sato, K. Matsuoka, K. Arai, T. Nakai, A. Hasegawa, N. Inoue, N. Watanabe, et al. Abnormally Differentiated Subsets of Intestinal Macrophage Play a Key Role in Th1-Dominant Chronic Colitis through Excess Production of IL-12 and IL-23 in Response to Bacteria J. Immunol., November 15, 2005; 175(10): 6900 - 6908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. He, T. T. Moore, F. O. Eko, D. Lyn, G. A. Ananaba, A. Martin, S. Singh, L. James, J. Stiles, C. M. Black, et al. Molecular Basis for the Potency of IL-10-Deficient Dendritic Cells as a Highly Efficient APC System for Activating Th1 Response J. Immunol., April 15, 2005; 174(8): 4860 - 4869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rey-Ladino, K. M. Koochesfahani, M. L. Zaharik, C. Shen, and R. C. Brunham A Live and Inactivated Chlamydia trachomatis Mouse Pneumonitis Strain Induces the Maturation of Dendritic Cells That Are Phenotypically and Immunologically Distinct Infect. Immun., March 1, 2005; 73(3): 1568 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, A. L. Carr, E. J. Donald, J. J. Skitzki, R. Okuyama, L. M. Stoolman, and A. E. Chang Synergistic Effects of IL-12 and IL-18 in Skewing Tumor-Reactive T-Cell Responses Towards a Type 1 Pattern Cancer Res., February 1, 2005; 65(3): 1063 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gervassi, M. R. Alderson, R. Suchland, J. F. Maisonneuve, K. H. Grabstein, and P. Probst Differential Regulation of Inflammatory Cytokine Secretion by Human Dendritic Cells upon Chlamydia trachomatis Infection Infect. Immun., December 1, 2004; 72(12): 7231 - 7239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Maxion, W. Liu, M.-H. Chang, and K. A. Kelly The Infecting Dose of Chlamydia muridarum Modulates the Innate Immune Response and Ascending Infection Infect. Immun., November 1, 2004; 72(11): 6330 - 6340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. O. Eko, Q. He, T. Brown, L. McMillan, G. O. Ifere, G. A. Ananaba, D. Lyn, W. Lubitz, K. L. Kellar, C. M. Black, et al. A Novel Recombinant Multisubunit Vaccine against Chlamydia J. Immunol., September 1, 2004; 173(5): 3375 - 3382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mandrekar, D. Catalano, A. Dolganiuc, K. Kodys, and G. Szabo Inhibition of Myeloid Dendritic Cell Accessory Cell Function and Induction of T Cell Anergy by Alcohol Correlates with Decreased IL-12 Production J. Immunol., September 1, 2004; 173(5): 3398 - 3407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Mao, M. D. Roth, K. J. Serio, F. Baratelli, L. Zhu, E. C. Holmes, R. M. Strieter, and S. M. Dubinett Celecoxib Modulates the Capacity for Prostaglandin E2 and Interleukin-10 Production in Alveolar Macrophages from Active Smokers Clin. Cancer Res., December 1, 2003; 9(16): 5835 - 5841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Colino and C. M. Snapper Opposing Signals from Pathogen-Associated Molecular Patterns and IL-10 Are Critical for Optimal Dendritic Cell Induction of In Vivo Humoral Immunity to Streptococcus pneumoniae J. Immunol., October 1, 2003; 171(7): 3508 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-R. Jiang, E. Muckersie, M. Robertson, H. Xu, J. Liversidge, and J. V. Forrester Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture J. Leukoc. Biol., November 1, 2002; 72(5): 978 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hawkins, R. G. Rank, and K. A. Kelly A Chlamydia trachomatis-Specific Th2 Clone Does Not Provide Protection against a Genital Infection and Displays Reduced Trafficking to the Infected Genital Mucosa Infect. Immun., September 1, 2002; 70(9): 5132 - 5139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Bontkes, T. D. de Gruijl, G. J. Schuurhuis, R. J. Scheper, C. J. L. M. Meijer, and E. Hooijberg Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome J. Leukoc. Biol., August 1, 2002; 72(2): 321 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harizi, M. Juzan, V. Pitard, J.-F. Moreau, and N. Gualde Cyclooxygenase-2-Issued Prostaglandin E2 Enhances the Production of Endogenous IL-10, Which Down-Regulates Dendritic Cell Functions J. Immunol., March 1, 2002; 168(5): 2255 - 2263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Darville, C. W. Andrews Jr., J. D. Sikes, P. L. Fraley, L. Braswell, and R. G. Rank Mouse Strain-Dependent Chemokine Regulation of the Genital Tract T Helper Cell Type 1 Immune Response Infect. Immun., December 1, 2001; 69(12): 7419 - 7424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hammad, A.-S. Charbonnier, C. Duez, A. Jacquet, G. A. Stewart, A.-B. Tonnel, and J. Pestel Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors Blood, August 15, 2001; 98(4): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Silva, T. F. Pais, and R. Appelberg Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination J. Immunol., August 1, 2001; 167(3): 1535 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Shaw, V. R. Grund, L. Durling, and H. D. Caldwell Expression of Genes Encoding Th1 Cell-Activating Cytokines and Lymphoid Homing Chemokines by Chlamydia-Pulsed Dendritic Cells Correlates with Protective Immunizing Efficacy Infect. Immun., July 1, 2001; 69(7): 4667 - 4672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Corinti, C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions J. Immunol., April 1, 2001; 166(7): 4312 - 4318. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
